• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姑息性切除或放疗原发肿瘤可延长转移性食管癌患者的生存时间。

Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer.

机构信息

Department of Medical Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Department of Radiology, The 901st Hospital of the Joint Logistics Support Force of PLA, Hefei, Anhui Province, China.

出版信息

Cancer Med. 2019 Dec;8(17):7253-7264. doi: 10.1002/cam4.2609. Epub 2019 Oct 14.

DOI:10.1002/cam4.2609
PMID:31612596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6885868/
Abstract

PURPOSE

We aimed to explore the value of palliative resection or radiation of primary tumor for metastatic esophageal cancer (EC) patients.

METHODS

Surveillance, Epidemiology, and End Results database was used for identifying metastatic EC patients. The patients were divided into resection and nonresection groups. And patients without resection were divided into radiation and nonradiation groups. Propensity score matching (PSM) analyses were adopted to reduce the baseline differences between the groups. Cancer specific survivals (CSSs) and overall survivals (OSs) were compared by Kaplan-Meier (K-M) curves. Multivariable analyses by COX proportion hazards model were performed to identify risk factors for CSS and OS. Predictive nomograms were conducted according to both postoperative factors and preoperative factors.

RESULTS

A total of 7982 metastatic EC patients were selected for our analyses. After PSM, 978 patients were included in the survival analyses comparing palliative resection and nonresection. The CSS and OS for patients underwent palliative resection were significantly longer than those without resection (median CSS: 21 months vs 7 months, P < .001; median OS: 20 months vs 7 months, P < .001). In the overall population without resection, 654 patients were matched for radiation and nonradiation groups. And K-M curves showed that patients with radiation had longer CSS and OS than those without radiation (median CSS: 11 months vs 6 months, P < .001; median OS: 10 months vs 6 months, P < .001). Nomograms were generated for prediction of 1-, 2-, and 3-year CSS and OS. All C-indexes implied moderate discrimination and accuracy. And all nomograms had good calibration.

CONCLUSION

Palliative resection or radiation of primary tumor could prolong CSS and OS of metastatic EC patients.

摘要

目的

本研究旨在探讨姑息性原发肿瘤切除术或放疗对转移性食管癌(EC)患者的价值。

方法

本研究利用监测、流行病学和最终结果数据库(SEER)确定转移性 EC 患者。将患者分为切除术组和非切除术组。非切除术组患者进一步分为放疗组和非放疗组。采用倾向评分匹配(PSM)分析以减少组间基线差异。采用 Kaplan-Meier(K-M)曲线比较两组的癌症特异性生存率(CSS)和总生存率(OS)。采用 COX 比例风险模型多变量分析确定 CSS 和 OS 的危险因素。根据术后和术前因素构建预测列线图。

结果

共纳入 7982 例转移性 EC 患者进行分析。经 PSM 后,978 例患者纳入姑息性切除术与非切除术生存分析。姑息性切除术患者的 CSS 和 OS 明显长于非切除术患者(中位 CSS:21 个月比 7 个月,P<0.001;中位 OS:20 个月比 7 个月,P<0.001)。在非切除术总体人群中,654 例患者按放疗和非放疗进行匹配。K-M 曲线显示,放疗组患者的 CSS 和 OS 长于非放疗组(中位 CSS:11 个月比 6 个月,P<0.001;中位 OS:10 个月比 6 个月,P<0.001)。构建了预测 1、2 和 3 年 CSS 和 OS 的列线图。所有 C 指数均提示具有中度判别能力和准确性。所有列线图均具有良好的校准度。

结论

姑息性原发肿瘤切除术或放疗可延长转移性 EC 患者的 CSS 和 OS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/ce4f688527bf/CAM4-8-7253-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/533ca57f3033/CAM4-8-7253-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/e9705c378424/CAM4-8-7253-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/c2faa0a7493b/CAM4-8-7253-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/ba25b3616081/CAM4-8-7253-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/982cb568be65/CAM4-8-7253-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/ce4f688527bf/CAM4-8-7253-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/533ca57f3033/CAM4-8-7253-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/e9705c378424/CAM4-8-7253-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/c2faa0a7493b/CAM4-8-7253-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/ba25b3616081/CAM4-8-7253-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/982cb568be65/CAM4-8-7253-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e7e/6885868/ce4f688527bf/CAM4-8-7253-g006.jpg

相似文献

1
Palliative resection or radiation of primary tumor prolonged survival for metastatic esophageal cancer.姑息性切除或放疗原发肿瘤可延长转移性食管癌患者的生存时间。
Cancer Med. 2019 Dec;8(17):7253-7264. doi: 10.1002/cam4.2609. Epub 2019 Oct 14.
2
Novel nomogram predicting cancer-specific survival and overall survival in patients with primary esophageal small-cell carcinoma: A surveillance, epidemiology, and end results-based study.基于监测、流行病学和最终结果的研究:用于预测原发性食管小细胞癌患者癌症特异性生存和总生存的新型列线图。
J Cancer Res Ther. 2021 Jul;17(3):630-637. doi: 10.4103/jcrt.JCRT_1612_20.
3
The primary tumor resection in patients with distant metastatic laryngeal carcinoma.远处转移喉癌患者的原发肿瘤切除术。
Eur Arch Otorhinolaryngol. 2020 Oct;277(10):2859-2868. doi: 10.1007/s00405-020-05987-9. Epub 2020 Apr 25.
4
Prognostic evaluation of esophageal cancer patients with stages I-III.Ⅰ-Ⅲ期食管癌患者的预后评估。
Aging (Albany NY). 2020 Jul 23;12(14):14736-14753. doi: 10.18632/aging.103532.
5
A novel nomogram with preferable capability in predicting the overall survival of patients after radical esophageal cancer resection based on accessible clinical indicators: A comparison with AJCC staging.一种基于可获得的临床指标,具有更好预测根治性食管癌切除术后患者总生存能力的新型列线图:与 AJCC 分期的比较。
Cancer Med. 2021 Jul;10(13):4228-4239. doi: 10.1002/cam4.3878. Epub 2021 Jun 15.
6
Is postoperative adjuvant radiotherapy necessary for patients with esophageal cancer after neoadjuvant chemoradiotherapy? An analysis based on the SEER database.新辅助放化疗后食管癌患者是否需要术后辅助放疗?基于 SEER 数据库的分析。
Saudi Med J. 2024 Aug;45(9):900-910. doi: 10.15537/smj.2024.45.9.20240045.
7
Comparative study of treatment options and construction nomograms to predict survival for early-stage esophageal cancer: a population-based study.早期食管癌治疗方案的比较研究及生存预测列线图的构建:基于人群的研究。
Scand J Gastroenterol. 2021 Jun;56(6):635-646. doi: 10.1080/00365521.2021.1910997. Epub 2021 Apr 19.
8
A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study.一种基于 SEER 的预测初诊转移性食管癌患者癌症特异性生存的新型列线图和风险分类系统。
Ann Surg Oncol. 2019 Feb;26(2):321-328. doi: 10.1245/s10434-018-6929-0. Epub 2018 Oct 24.
9
Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.手术对 III 期 N2 小细胞肺癌患者生存的影响:倾向评分匹配分析和列线图的建立和验证。
World J Surg Oncol. 2021 Aug 30;19(1):258. doi: 10.1186/s12957-021-02364-6.
10
Identification of optimal primary tumor resection candidates for metastatic gastric cancer: Nomograms based on propensity score matching.基于倾向评分匹配的转移性胃癌最佳原发灶切除候选者的识别:列线图。
Cancer Med. 2023 Jun;12(12):13063-13075. doi: 10.1002/cam4.5983. Epub 2023 Apr 25.

引用本文的文献

1
Locally advanced and metastatic esophageal squamous cell carcinoma in Morocco: from diagnosis to treatment.摩洛哥局部晚期和转移性食管鳞状细胞癌:从诊断到治疗
Ecancermedicalscience. 2025 Apr 1;19:1882. doi: 10.3332/ecancer.2025.1882. eCollection 2025.
2
Primary tumor resection might improve outcomes in metastatic thoracic esophageal cancer.原发性肿瘤切除可能改善转移性胸段食管癌的预后。
Sci Rep. 2025 Jan 24;15(1):3054. doi: 10.1038/s41598-025-85419-y.
3
Comparative Analysis of Concurrent Chemoradiotherapy Versus Chemotherapy Alone as First-Line Palliative Treatments for Advanced Esophageal Squamous Cell Carcinoma.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Long-term survival after multimodality therapy including surgery for metastatic esophageal cancer.包括手术在内的多模式治疗后转移性食管癌的长期生存情况。
Acta Chir Belg. 2018 Aug;118(4):227-232. doi: 10.1080/00015458.2017.1411557. Epub 2017 Dec 19.
3
Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer.
同步放化疗与单纯化疗作为晚期食管鳞状细胞癌一线姑息治疗的对比分析
J Clin Med. 2024 Oct 23;13(21):6353. doi: 10.3390/jcm13216353.
4
Surgical and multimodal treatment of metastatic oesophageal cancer: retrospective cohort study.外科和多模式治疗转移性食管鳞癌:回顾性队列研究。
BJS Open. 2024 May 8;8(3). doi: 10.1093/bjsopen/zrae054.
5
A predictive scoring model to select suitable patients for surgery on primary tumor in metastatic esophageal cancer.预测评分模型选择适合转移性食管癌原发灶手术的患者。
Cancer Rep (Hoboken). 2023 Dec;6(12):e1898. doi: 10.1002/cnr2.1898. Epub 2023 Sep 13.
6
Surgical resection of primary tumors improves survival in patients with lung metastases: a population-based SEER analysis.原发性肿瘤的手术切除可提高肺转移患者的生存率:一项基于人群的监测、流行病学和最终结果(SEER)分析。
Transl Cancer Res. 2023 May 31;12(5):1128-1144. doi: 10.21037/tcr-22-2459. Epub 2023 Apr 20.
7
A machine learning model predicting candidates for surgical treatment modality in patients with distant metastatic esophageal adenocarcinoma: A propensity score-matched analysis.预测远处转移性食管腺癌患者手术治疗方式候选者的机器学习模型:倾向评分匹配分析
Front Oncol. 2022 Jul 22;12:862536. doi: 10.3389/fonc.2022.862536. eCollection 2022.
8
Chemoradiotherapy Versus Chemotherapy Alone for Advanced Esophageal Squamous Cell Carcinoma: The Role of Definitive Radiotherapy for Primary Tumor in the Metastatic Setting.同步放化疗与单纯化疗治疗晚期食管鳞状细胞癌:在转移情况下,根治性放疗对原发性肿瘤的作用。
Front Oncol. 2022 Mar 30;12:824206. doi: 10.3389/fonc.2022.824206. eCollection 2022.
9
The Effect of the Appropriate Timing of Radiotherapy on Survival Benefit in Patients with Metastatic Esophageal Cancer Who Have Undergone Resection of Primary Site: A SEER Database Analysis.原发部位切除术后的转移性食管癌患者放疗时机对生存获益的影响:一项监测、流行病学与最终结果(SEER)数据库分析
J Oncol. 2022 Mar 16;2022:6086953. doi: 10.1155/2022/6086953. eCollection 2022.
10
Update on Management of Squamous Cell Esophageal Cancer.食管鳞状细胞癌管理的最新进展
Curr Oncol Rep. 2022 Mar;24(3):375-385. doi: 10.1007/s11912-021-01153-4. Epub 2022 Feb 10.
姑息性胃切除术对某些转移性胃癌病例有益。
BMC Palliat Care. 2017 Mar 14;16(1):19. doi: 10.1186/s12904-017-0192-1.
4
Survival After Surgical Resection of Stage IV Esophageal Cancer.IV期食管癌手术切除后的生存率
Ann Thorac Surg. 2017 Jan;103(1):261-266. doi: 10.1016/j.athoracsur.2016.06.070. Epub 2016 Sep 9.
5
Does surgery have a role in managing incurable gastric cancer?手术在无法治愈的胃癌的治疗中有作用吗?
Nat Rev Clin Oncol. 2015 Nov;12(11):676-82. doi: 10.1038/nrclinonc.2015.132. Epub 2015 Aug 11.
6
Surgical Resection of Primary Tumor in Asymptomatic or Minimally Symptomatic Patients With Stage IV Colorectal Cancer: A Canadian Province Experience.对无症状或症状轻微的IV期结直肠癌患者进行原发性肿瘤的手术切除:加拿大一个省的经验。
Clin Colorectal Cancer. 2015 Dec;14(4):e41-7. doi: 10.1016/j.clcc.2015.05.008. Epub 2015 Jun 6.
7
Esophageal and esophagogastric junction cancers, version 1.2015.食管和胃食管交界处癌,第 1.2015 版。
J Natl Compr Canc Netw. 2015 Feb;13(2):194-227. doi: 10.6004/jnccn.2015.0028.
8
Comparing two correlated C indices with right-censored survival outcome: a one-shot nonparametric approach.比较两个具有右删失生存结局的相关C指数:一种一次性非参数方法。
Stat Med. 2015 Feb 20;34(4):685-703. doi: 10.1002/sim.6370. Epub 2014 Nov 17.
9
Survival impact of surgical resection of primary tumor in patients with stage IV colorectal cancer: results from a large population-based cohort study.手术切除原发肿瘤对 IV 期结直肠癌患者生存的影响:一项大型基于人群的队列研究结果。
Cancer. 2014 Mar 1;120(5):683-91. doi: 10.1002/cncr.28464. Epub 2013 Nov 12.
10
Epidemiology of esophageal cancer.食管癌的流行病学。
World J Gastroenterol. 2013 Sep 14;19(34):5598-606. doi: 10.3748/wjg.v19.i34.5598.